Before the panel
Identified before the data
We know them already — so they are on the list this cycle, not the next one.
Active HCPs to consider before the panel ships
Intelligence for your hardest-to-reach prescribers.
We find them. Then we reach them. Daily.
See Who We FindBreakout Prescribers
Your next growth curve is already prescribing. You just haven't met them.
Three archetypes drive growth and sit outside conventional promotion.
Beyond the panel
Named beyond the panel
Named, segmented, engaged and measured alongside everyone else you count.
NPs, PAs and advanced practice clinicians
Behind the door
Found behind the door
We find the condition on which the answer changes — the channel, the setting, the voice — then we meet them there.
Zero to two promotional engagements a year
It always starts the same way: we map your panel against the archetype and hand you the number.
What you do with it is your call — and we can do that too.
Why We Exist
Between a medicine that works and a patient who is taking it, there is a distance.
It is measured in time, and every gap in it is someone waiting longer than they should.
That distance is never random. It has three causes, and all three are knowable.
Timing
Data describes what has already happened. Some clinicians move faster than the record of them, and the gap belongs to no one. The distance here is a lag — and it closes on its own schedule, not yours.
Structure
The clinician who writes the script and the record that receives credit are not always the same. Volume routes upward, to a supervising name or an institution. The distance here is an accounting artifact — and it is correctable.
Preference
Not every closed door is a refusal. I don’t want to see reps. I’m not allowed to. Underneath most of them is a condition on which they would. The distance here is a channel mismatch — and the condition can be pinpointed.
We find which one you are facing, for every clinician on your panel and every one who should be. Then we go where our clients cannot — because we are not the rep, not the brand, not the company that makes the medicine.
So measure us this way:
Time to first dose.
Not impressions. Not clicks. Not reach.
Our work is the bridge. That is the path — and that is what we share.
Leadership Team
Great medicines deserve a trusted path into clinical conversation.
Looking Forward
The next decade of prescribing is being decided now.
More of it every year belongs to clinicians the call panel was never built to find. We are already in the room with them.
Start a Conversation